Using biological mesh for pelvic floor reconstruction after extralevator abdominoperineal resection in low rectal cancer patients does not provide a cost-effective solution despite slightly reducing perineal complications.
- Pelvic reconstruction with biological mesh increased costs (€57,991) versus primary closure (€56,232) without significant improvement in long-term patient outcomes or quality of life.
- The study’s conclusions suggest routine use of biological mesh is not justified from a cost-effectiveness standpoint.
Surgeons should carefully consider the financial and clinical implications of using biological mesh in this context.
Video-Audio Media by van den Berg R, Musters GD (…) Tanis PJ et 15 al. in Dis Colon Rectum
Copyright © 2026 The Author(s). Published by Wolters Kluwer Health, LLC. on behalf of the American Society of Colon and Rectal Surgeons.